NEW YORK (GenomeWeb) – Trovagene reported after the close of the market on Monday a 7 percent decline year over year in revenues for the first quarter, as well as a steep increase in its net loss.

The San Diego developer of cell-free molecular diagnostics said that for the three months ended March 31, revenues shrank to $111,000 from $119,000.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Mary Beckerle has been removed as director of the Huntsman Cancer Institute in what one researcher refers to as a "coup," ScienceInsider reports.

Bill Gates tells the Telegraph that bioterrorism is a serious risk.

The March for Science is to take place tomorrow, and supporters are tapping their creative energies to create placards to carry.

CBS News reports that the White House Science Fair is to continue under President Donald Trump.

May
04
Sponsored by
Qiagen

This online seminar will provide an overview of the use of liquid biopsies for cancer recurrence monitoring with a particular focus on colorectal cancer.

May
11
Sponsored by
PerkinElmer

This webinar will provide an overview of an RNA-seq protocol that has been optimized to study small RNA species such as microRNAs.

May
23
Sponsored by
Agilent Technologies

This webinar will discuss a target enrichment workflow for high-confidence detection of variants. 

Jun
20
Sponsored by
OmniSeq

This webinar will discuss RNA sequencing as an alternative to immunohistochemistry (IHC) in selecting patients for cancer immunotherapy.